Eden Well being is a direct-to-employer healthcare supplier that makes a speciality of digital main care, insurance coverage navigation and office pop-up clinics. The New York firm notes that it has seen a 500% improve in curiosity from employers and industrial property homeowners for the reason that begin of COVID-19, and is now providing a back-to-work screening and testing providing. It didn’t specify how the brand new funds could be employed.
“What employers are realizing is that they’ve a duty to handle their total workforce’s bodily and emotional well being,” Matt McCambridge, CEO and cofounder of Eden Well being, mentioned in a press release. “The optimum administration of workforce well being meets that particular person and their member of the family the place they’re, whether or not it is at their worksite, at house, or locally. With at present’s funding and the advances we have developed, we’re set to radically enhance care supply and well being outcomes.”
Bodyport, the maker of a related lavatory scale for monitoring cardiac biomarkers within the house, has wrapped up an $11.2 million Sequence A elevate led by Boehringer Ingelheim Enterprise Fund. Playground World, Initialized Capital and different unnamed backers additionally participated within the spherical, which brings the startup’s complete elevate to $15.eight million.
Bodyport mentioned that the elevate will likely be used to “deepen key well being partnerships,” in addition to to kick off a distant monitoring-based “digital cardiac clinic.” Information of the elevate additionally got here with phrase on a brand new collaboration between the startup and Brigham and Girls’s Hospital that will likely be centered on early heart problems detection and the prevention of avoidable hospitalizations.
“Even though heart problems is basically preventable, it stays the main international reason behind loss of life,” Corey Centen, CEO and cofounder of Bodyport, mentioned in a press release. “We’re centered on altering the way in which sufferers and care groups handle coronary heart illness. By shifting the know-how sufferers can entry from a scientific setting to their very own house, we’re aiming to foretell adjustments in well being standing earlier than a hospital go to turns into vital. Finally, this early detection might assist push care supply away from its reactive mannequin, lowering prices and drastically bettering the standard of life for sufferers coping with power illness.”
Reify Well being, a Boston-based firm specializing in cloud-based scientific trial software program, has raised $30 million in Sequence B funding. Battery Ventures headed the spherical, which additionally included prior backers Sierra Ventures and Asset Administration Ventures.
The startup’s StudyTeam platform seems to be to hurry up scientific trial enrollment and cut back workload burdens by dealing with redundant processes and highlighting data-driven insights. The corporate mentioned that the know-how has thus far been utilized by 1,800 analysis websites throughout 26 international locations.
With the brand new funds, the corporate will proceed to increase its platform.
“We see great alternative for Reify Well being to rework the life sciences business and are thrilled to accomplice with them to deliver life-saving medicine to sufferers sooner,” Neeraj Agrawal, common accomplice at Battery Ventures, mentioned in a press release.
Encino, California-based mPulse Cell has raised “greater than $16 million” in Sequence C funding. The Optum Ventures-led spherical included contributions from present buyers equivalent to HLM Enterprise Companions, OCA Ventures, SJF Ventures, Echo Well being Ventures and Rincon Ventures.
The corporate makes use of AI to automate conversations between customers and healthcare organizations. mPulse Cell says it has offered the know-how to greater than 100 healthcare organizations in its lifetime, and that it helps greater than 300 million conversations per yr.
“This new funding acknowledges that scale and resolution efficiency are key elements in efficiently participating customers of their healthcare, and we’ll use it to increase our shopper conversational AI capabilities, improve our consumer engagement analytics platform and increase our engagement options throughout healthcare verticals,” CEO Chris Nicholson mentioned in a press release.
Retina-AI Well being, a startup creating screening software program for diabetic retinopathy detection, has raised $5.2 million in Sequence A funding from non-public buyers and Shipt founder Invoice Smith. With this, CEO Dr. Stephen Odaibo mentioned that it will be pushing its product by way of FDA regulatory approval.
“The confluence of value-based healthcare supply and synthetic intelligence gives a tangible and well timed alternative for constructive impression,” he mentioned in a press release.
Milwaukee-based healthcare funds and income cycle administration startup Sift Healthcare has introduced in $2.eight million in funding, $1.875 of which is new fairness from Rock River Capital Companions, Winnebago Seed Fund and different buyers.
Sift mentioned these funds will assist construct out its information science and information engineering groups because it seems to be to satisfy new calls for for its AI instruments.
“We’re honored to have dedicated buyers who acknowledge the well timed alternative to innovate within the healthcare funds area,” Justin Nicols, founder and CEO of Sift, mentioned in a press release. “I’m significantly proud that our buyers are Wisconsin-based and dedicated to rising tech corporations inside our state.”
Clearstep Well being, maker of an AI care-navigation device for in-person or digital care, has collected $1.three million in pre-seed funding. RRE Ventures, Newark Enterprise Companions and OCA Ventures all participated.
Noting new use of its know-how as a COVID-19 screener with Hartford HealthCare and BayCare Well being, the corporate mentioned that it is going to be making new hires to help product improvement and enterprise improvement.
“The realities of the previous few months have reinvigorated us to pursue radical change in healthcare,” Adeel Malik, CEO and cofounder of Clearstep, mentioned in a press release. “In mild of the challenges the pandemic has surfaced, we’ve seen new and widespread recognition by healthcare organizations of the worth in novel care navigation options like Clearstep. Our workforce is tremendously excited to proceed reworking how customers are ready discover and entry the suitable care, and [we] are thrilled to additional speed up our progress with the backing of such nice buyers.”